Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial by Pignata, Sandro, MD, Lorusso, Domenica, MD, Joly, Florence, MD, Gallo, Ciro, Prof, Colombo, Nicoletta, Prof, Sessa, Cristiana, Prof, Bamias, Aristotelis, Prof, Salutari, Vanda, MD, Selle, Frédèric, MD, Frezzini, Simona, MD, De Giorgi, Ugo, MD, Pautier, Patricia, MD, Bologna, Alessandra, MD, Orditura, Michele, Prof, Dubot, Coraline, MD, Gadducci, Angiolo, Prof, Mammoliti, Serafina, MD, Ray-Coquard, Isabelle, Prof, Zafarana, Elena, MD, Breda, Enrico, MD, Favier, Laure, MD, Ardizzoia, Antonio, MD, Cinieri, Saverio, Prof, Largillier, Rémy, MD, Sambataro, Daniela, MD, Guardiola, Emmanuel, MD, Lauria, Rossella, MD, Pisano, Carmela, MD, Raspagliesi, Francesco, MD, Scambia, Giovanni, MD, Daniele, Gennaro, MD, Perrone, Francesco, MD

Get full text

Patient-centred outcomes and effect of disease progression on health status in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation receiving maintenance olapa... by Friedlander, Michael, Prof, Moore, Kathleen N, Prof, Colombo, Nicoletta, Prof, Scambia, Giovanni, Prof, Kim, Byoung-Gie, Prof, Oaknin, Ana, Prof, Lisyanskaya, Alla, MD, Sonke, Gabe S, Prof, Gourley, Charlie, Prof, Banerjee, Susana, PhD, Oza, Amit, Prof, González-Martín, Antonio, MD, Aghajanian, Carol, Prof, Bradley, William H, MD, Liu, Joyce, MD, Mathews, Cara, MD, Selle, Frédéric, MD, Lortholary, Alain, MD, Lowe, Elizabeth S, MD, Hettle, Robert, MMath, Flood, Emuella, BA, Parkhomenko, Elena, PhD, DiSilvestro, Paul, Prof

Get full text

Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial by Pautier, Patricia, Dr, Floquet, Anne, MD, Chevreau, Christine, MD, Penel, Nicolas, MD, Guillemet, Cécile, MD, Delcambre, Corinne, MD, Cupissol, Didier, MD, Selle, Frédéric, MD, Isambert, Nicolas, MD, Piperno-Neumann, Sophie, MD, Thyss, Antoine, Prof, Bertucci, François, Prof, Bompas, Emmanuelle, MD, Alexandre, Jerôme, Prof, Collard, Olivier, MD, Lavau-Denes, Sandrine, MD, Soulié, Patrick, MD, Toulmonde, Maud, MD, Le Cesne, Axel, MD, Lacas, Benjamin, MSc, Duffaud, Florence, Prof

Get full text

Efficacy of niraparib by timing of surgery and residual disease: a post-hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study by O'Cearbhaill, Roisin, MD, Pérez-Fidalgo, Jose Alejandro, MD PhD, Monk, Bradley, MD, FACS, FACOG, Tusquets, Ignasi, MD, McCormick, Colleen, MD, MPH, Fuentes, Jose, MD PhD, Moore, Richard, MD, Vulsteke, Christof, MD PhD, Shahin, Mark, MD, Forget, Frédéric, Bradley, William, MD, Hietanen, Sakari, MD, O'Malley, David, MD, Dørum, Anne, MD, Slomovitz, Brian, MD, Baumann, Klaus, MD, PhD, Selle, Frédéric, MD, Calvert, Paula, MD, Artioli, Grazia, MD, Levy, Tally, MD, Kumar, Aalok, MD, Malinowska, Izabela, MD, PhD, Li, Yong, PhD, Gupta, Divya, MD, González-Martín, Antonio, MD, PhD

Get full text

Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer by Chéreau, Elisabeth, MD, Ballester, Marcos, MD, Selle, Frédéric, MD, Cortez, Annie, MD, Daraï, Emile, MD, PhD, Rouzier, Roman, MD, PhD

Get full text

Spontaneous rectovaginal fistula during bevacizumab therapy for ovarian cancer: a case report by Chéreau, Elisabeth, MD, Stefanescu, Dan, MD, Selle, Frédéric, MD, Rouzier, Roman, MD, PhD, Daraï, Emile, MD, PhD

Get full text

Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-... by Pujade-Lauraine, Eric, Prof, Ledermann, Jonathan A, Prof, Selle, Frédéric, MD, Gebski, Val, Prof, Penson, Richard T, MD, Oza, Amit M, Prof, Korach, Jacob, MD, Huzarski, Tomasz, MD, Poveda, Andrés, MD, Pignata, Sandro, Prof, Friedlander, Michael, Prof, Colombo, Nicoletta, Prof, Harter, Philipp, MD, Fujiwara, Keiichi, Prof, Ray-Coquard, Isabelle, Prof, Banerjee, Susana, PhD, Liu, Joyce, MD, Lowe, Elizabeth S, MD, Bloomfield, Ralph, MSc, Pautier, Patricia, MD

Get full text

Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial by Oza, Amit M, Prof, Cook, Adrian D, MSc, Pfisterer, Jacobus, Prof, Embleton, Andrew, MSc, Ledermann, Jonathan A, Prof, Pujade-Lauraine, Eric, Prof, Kristensen, Gunnar, Prof, Carey, Mark S, MD, Beale, Philip, MD, Cervantes, Andrés, Prof, Park-Simon, Tjoung-Won, Prof, Rustin, Gordon, Prof, Joly, Florence, Prof, Mirza, Mansoor R, MD, Plante, Marie, MD, Quinn, Michael, Prof, Poveda, Andrés, MD, Jayson, Gordon C, Prof, Stark, Dan, MD, Swart, Ann Marie, Prof, Farrelly, Laura, MSc, Kaplan, Richard, Prof, Parmar, Mahesh K B, Prof, Perren, Timothy J, Prof

Get full text

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, r... by Poveda, Andrés, MD, Floquet, Anne, MD, Ledermann, Jonathan A, Prof, Asher, Rebecca, MSc, Penson, Richard T, MD, Oza, Amit M, Prof, Korach, Jacob, MD, Huzarski, Tomasz, MD, Pignata, Sandro, Prof, Friedlander, Michael, Prof, Baldoni, Alessandra, MD, Park-Simon, Tjoung-Won, Prof, Tamura, Kenji, MD, Sonke, Gabe S, MD, Lisyanskaya, Alla, MD, Kim, Jae-Hoon, Prof, Filho, Elias Abdo, MD, Milenkova, Tsveta, MD, Lowe, Elizabeth S, MD, Rowe, Phil, MSc, Vergote, Ignace, Prof, Pujade-Lauraine, Eric, Prof

Get full text